Einsele Arthur
Internutrition, Postfach, 8035, Zurich, Switzerland.
Adv Biochem Eng Biotechnol. 2007;107:1-11. doi: 10.1007/10_2007_055.
Although the global area of biotech crops continues to climb for the tenth consecutive year at a sustainable double-digit growth rate, the acceptance of biotech products from agriculture in Europe is still low. There is a gap between science and perception. It is a strong belief that the public turning against science and against GM food has been encouraged by the negative activities of NGO groups. Scientists have to overcome the purely risk-based discussion, and the benefits of plant biotechnology have to be made literally visible. GM food should be available, the benefits should be tangible and the consumer should have fun with such novel food. The gap could be reduced if genetically modified plants and the products thereof were regulated in the same way as classical products.
尽管全球转基因作物种植面积连续第十年以两位数的可持续增长率攀升，但欧洲农业生物技术产品的接受度仍然很低。科学与认知之间存在差距。人们坚信，非政府组织的负面活动助长了公众对科学和转基因食品的抵触情绪。科学家们必须克服单纯基于风险的讨论，切实展示植物生物技术的益处。转基因食品应供应充足，益处应切实可见，消费者应对这类新奇食品感兴趣。如果对转基因植物及其产品的监管方式与传统产品相同，那么这种差距可能会缩小。
